An FDA advisory board voted unanimously Friday to say that the agency disregarded significant evidence about bishpenol A safety.

Federal regulators issued a draft report in August which said that levels of bisphenol A found in baby bottles and other household products were safe, was based on “all available evidence.”

The controversial organic compound which is commonly used in baby bottles and canned foods was thought to be harmful to fetuses, infants and children. But the FDA said the plastic industry was right when it claimed that the chemical, a synthetic estrogen resembling the natural hormone with the same name, didn’t induce toxicity in humans at typical levels of exposure.

Earlier in April, when the National Toxicology Program released a draft report raising concern about the hormone-disrupting chemical, a debate was started. Since then, several major corporations, such as Wal-Mart and Babies “R” Us, stopped manufacturing products containing BPA.

"The margins of safety defined by FDA as adequate are not adequate," according to Martin Philbert, chairman of a seven-member subcommittee commissioned by the Food and Drug Administration’s Science Board to assess the agency's findings concerning BPA

Infants are frequently exposed to the chemical from plastic baby bottles. And, as tests revealed, BPA was present in no less than 93 percent of Americans. Following the scandal, the Environmental Working Group and Consumers Union, asked the Science Board to ban the chemical right away.